OSIR
RhumbLine Advisers’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-20,882
| Closed | -$103K | – | 2885 |
|
|
2016
Q4 | $103K | Buy |
20,882
+1,313
| +7% | +$6.48K | ﹤0.01% | 2793 |
|
|
2016
Q3 | $97K | Hold |
19,569
| – | – | ﹤0.01% | 2813 |
|
|
2016
Q2 | $100K | Buy |
19,569
+95
| +0.5% | +$485 | ﹤0.01% | 2916 |
|
|
2016
Q1 | $111K | Buy |
19,474
+290
| +2% | +$1.65K | ﹤0.01% | 2876 |
|
|
2015
Q4 | $199K | Sell |
19,184
-505
| -3% | -$5.24K | ﹤0.01% | 2802 |
|
|
2015
Q3 | $364K | Buy |
19,689
+635
| +3% | +$11.7K | ﹤0.01% | 2431 |
|
|
2015
Q2 | $371K | Sell |
19,054
-1,180
| -6% | -$23K | ﹤0.01% | 2523 |
|
|
2015
Q1 | $356K | Buy |
20,234
+2,100
| +12% | +$36.9K | ﹤0.01% | 2518 |
|
|
2014
Q4 | $290K | Buy |
18,134
+575
| +3% | +$9.2K | ﹤0.01% | 2608 |
|
|
2014
Q3 | $221K | Buy |
17,559
+200
| +1% | +$2.52K | ﹤0.01% | 2694 |
|
|
2014
Q2 | $271K | Buy |
17,359
+1,290
| +8% | +$20.1K | ﹤0.01% | 2661 |
|
|
2014
Q1 | $211K | Sell |
16,069
-800
| -5% | -$10.5K | ﹤0.01% | 2747 |
|
|
2013
Q4 | $271K | Hold |
16,869
| – | – | ﹤0.01% | 2651 |
|
|
2013
Q3 | $281K | Sell |
16,869
-171
| -1% | -$2.85K | ﹤0.01% | 2579 |
|
|
2013
Q2 | $172K | Buy |
+17,040
| New | +$172K | ﹤0.01% | 3061 |
|